Development of a Bispecific Antibody Targeting CD30 and CD137 on Hodgkin and Reed-Sternberg Cells

Hodgkin Lymphoma (HL) is a malignancy that frequently affects young adults. Although, there are effective treatments not every patient responds, necessitating the development of novel therapeutic approaches, especially for relapsed and refractory cases. The two TNF receptor family members CD30 and C...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajendran, Sakthi, Li, Yating, Ngoh, Evelyn, Wong, Hiu Yi, Cheng, Man Si, Wang, Cheng-I, Schwarz, Herbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768943/
https://www.ncbi.nlm.nih.gov/pubmed/31616638
http://dx.doi.org/10.3389/fonc.2019.00945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768943/
https://www.ncbi.nlm.nih.gov/pubmed/31616638
http://dx.doi.org/10.3389/fonc.2019.00945

Ejemplares similares